• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

假二糖新霉素胺作为新霉素生物合成中间体的作用。

The role of the pseudo-disaccharide neamine as an intermediate in the biosynthesis of neomycin.

作者信息

Pearce C J, Barnett J E, Anthony C, Akhtar M, Gero S D

出版信息

Biochem J. 1976 Dec 1;159(3):601-6. doi: 10.1042/bj1590601.

DOI:10.1042/bj1590601
PMID:1008820
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1164158/
Abstract

By using wild-type and deoxystreptamine-negative mutants of Streptomyces fradiae grown in media containing [6(-3)H]glucose or [U-14C]glucose, and by subsequent hydrolysis of the labelled neomycin produced, neamines labelled with 3H in both rings I and II, but with 14C in ring I only, were prepared. A mixture of these two forms of neamine was converted by deoxystreptamine-negative Streptomyces rimosus forma paromomycinus into neomycin (not paromomycin) with a 30% yield. The3H: 14C ratio in this neomycin was the same as the measured in neamine produced by hydrolysis of the neomycin, and in unused neamine reisolated from the incubation medium. The 3H:14C ratio in the neomycin was not affected by the presence of unlabelled deoxystreptamine during the incubation. The radioactivity in the neomycin was associated with rings I and II only. It is concluded that the added neamine is incorporated into antibiotic intact, without initial hydrolysis, and that the probable first step in the subunit assembly of neomycin is the formation of neamine.

摘要

通过使用在含有[6(-3)H]葡萄糖或[U-14C]葡萄糖的培养基中生长的野生型和去氧链霉胺阴性突变型弗氏链霉菌,并通过随后对产生的标记新霉素进行水解,制备了在环I和环II中都用3H标记但仅在环I中用14C标记的新霉胺。这两种形式的新霉胺的混合物被去氧链霉胺阴性的龟裂链霉菌副伤寒亚种转化为新霉素(而非巴龙霉素),产率为30%。该新霉素中的3H:14C比率与新霉素水解产生的新霉胺中以及从培养培养基中重新分离出的未使用的新霉胺中测得的比率相同。新霉素中的3H:14C比率在培养期间不受未标记的去氧链霉胺存在的影响。新霉素中的放射性仅与环I和环II相关。得出的结论是,添加的新霉胺完整地掺入抗生素中,没有初始水解,并且新霉素亚基组装中可能的第一步是新霉胺的形成。

相似文献

1
The role of the pseudo-disaccharide neamine as an intermediate in the biosynthesis of neomycin.假二糖新霉素胺作为新霉素生物合成中间体的作用。
Biochem J. 1976 Dec 1;159(3):601-6. doi: 10.1042/bj1590601.
2
Sub-unit assembly in the biosynthesis of neomycin. The synthesis of 5-O-beta-D-ribofuranosyl and 4-O-beta-D-ribofuranosyl-2,6-dideoxystreptamines.
J Antibiot (Tokyo). 1978 Jan;31(1):74-81. doi: 10.7164/antibiotics.31.74.
3
6"'-Deamino-6"'-hydroxy derivatives, as intermediates in the biosynthesis of neomycin and paromomycin.
J Antibiot (Tokyo). 1981 May;34(5):536-43. doi: 10.7164/antibiotics.34.536.
4
Neomycin biosynthesis: the incorporation of D-6-deoxy-glucose derivatives and variously labelled glucose into the 2-deoxystreptamine ring. Postulated involvement of 2-deoxyinosose synthase in the biosynthesis.新霉素的生物合成:D-6-脱氧葡萄糖衍生物和各种标记葡萄糖掺入2-脱氧链霉胺环。推测2-脱氧肌醇合酶参与生物合成。
J Antibiot (Tokyo). 1992 Jun;45(6):984-94. doi: 10.7164/antibiotics.45.984.
5
Isolation and characterization of three phosphoamido-neomycins and their conversion into neomycin by Streptomyces fradiae.三种磷酰胺基新霉素的分离、表征及其被弗氏链霉菌转化为新霉素的过程
Biochem J. 1970 Nov;120(2):271-8. doi: 10.1042/bj1200271.
6
Neomycin biosynthesis: the involvement of neamine and paromamine as intermediates.新霉素的生物合成:新霉胺和巴龙胺作为中间体的参与情况。
J Antibiot (Tokyo). 1984 Jan;37(1):77-9. doi: 10.7164/antibiotics.37.77.
7
Interspecific recombination among aminoglycoside producing streptomycetes.
J Antibiot (Tokyo). 1981 May;34(5):544-50. doi: 10.7164/antibiotics.34.544.
8
Mutational biosynthesis of neomycin analogs by a mutant of neomycin-producing Streptomyces fradiae.通过新霉素产生链霉菌突变株的突变生物合成新霉素类似物。
Folia Microbiol (Praha). 2011 Nov;56(6):555-61. doi: 10.1007/s12223-011-0082-5. Epub 2011 Nov 15.
9
The neomycin biosynthetic gene cluster of Streptomyces fradiae NCIMB 8233: characterisation of an aminotransferase involved in the formation of 2-deoxystreptamine.弗氏链霉菌NCIMB 8233的新霉素生物合成基因簇:参与2-脱氧链霉胺形成的一种转氨酶的特性分析
Org Biomol Chem. 2005 Apr 21;3(8):1410-8. doi: 10.1039/b501199j. Epub 2005 Mar 21.
10
[Protoplast fusion in Streptomyces fradiae strains producing neomycin and tylosin].[弗氏链霉菌产生新霉素和泰乐菌素菌株中的原生质体融合]
Antibiot Khimioter. 1992 Oct;37(10):3-7.

本文引用的文献

1
The synthesis of neomycin-C14 by Streptomyces fradiae.弗氏链霉菌合成新霉素-C14 。
Arch Biochem Biophys. 1955 Jul;57(1):71-9. doi: 10.1016/0003-9861(55)90178-8.
2
Quantitative determination of the components of neomycin by paper chromatography.用纸上色谱法对新霉素各组分进行定量测定。
Anal Chem. 1967 Feb;39(2):215-7. doi: 10.1021/ac60246a034.
3
Studies on antibiotic SF-733, a new antibiotic. I. Taxonomy, isolation and characterization.新型抗生素SF-733的研究。I. 分类学、分离与特性鉴定。
J Antibiot (Tokyo). 1970 Mar;23(3):155-61. doi: 10.7164/antibiotics.23.155.
4
Studies on antibiotic SF-733. A new antibiotic. II. Chemical structure of antibiotic SF-733.抗生素SF-733的研究。一种新型抗生素。II. 抗生素SF-733的化学结构。
J Antibiot (Tokyo). 1970 Apr;23(4):173-83. doi: 10.7164/antibiotics.23.173.
5
Preparation of four new antibiotics from a mutant of Streptomyces fradiae.从弗氏链霉菌突变体中制备四种新型抗生素。
Proc Natl Acad Sci U S A. 1969 May;63(1):198-204. doi: 10.1073/pnas.63.1.198.
6
Biosynthetic incorporation of (1-13C)glucosamine and (6-13C)glucose into neomycin.(1-¹³C)氨基葡萄糖和(6-¹³C)葡萄糖生物合成掺入新霉素的过程。
J Am Chem Soc. 1974 Apr 3;96(7):2263-5. doi: 10.1021/ja00814a053.
7
Letter: Microbial semi-synthesis of aminoglycosidic antibiotics by mutants of S. ribosidificus and S. kanamyceticus.
J Antibiot (Tokyo). 1973 Dec;26(12):784-6. doi: 10.7164/antibiotics.26.784.
8
Chromatographic analysis of neomycin. Isolation and identification of minor components.新霉素的色谱分析。次要成分的分离与鉴定。
J Antibiot (Tokyo). 1974 Dec;27(12):931-42. doi: 10.7164/antibiotics.27.931.
9
Use of mutants in the study of aminocyclitol antibiotic biosynthesis and the preparation of the hybrimycin C complex.
Biochemistry. 1974 Dec 3;13(25):5073-8. doi: 10.1021/bi00722a002.
10
Biotransformation, a new approach to aminoglycoside biosynthesis. I. Sisomicin.
J Antibiot (Tokyo). 1975 Aug;28(8):573-9. doi: 10.7164/antibiotics.28.573.